US Broker Ratings

Takeda Pharmaceutical (TAK): Investor Outlook on Robust Revenue Growth and Strong Analyst Ratings

As one of the oldest and most established players in the global pharmaceutical landscape, Takeda Pharmaceutical Company Limited (NYSE: TAK) continues to capture the attention of investors with its significant..

Hologic, Inc. (HOLX) Stock Analysis: A Steady Performer in the Healthcare Sector

As investors navigate the ever-evolving landscape of the healthcare sector, Hologic, Inc. (NASDAQ: HOLX) stands out as a robust player, specializing in medical instruments and supplies with a market capitalization..

Waters Corporation (WAT) Stock Analysis: Unlocking 19.42% Potential Upside in the Healthcare Diagnostics Sector

Investors eyeing opportunities in the healthcare diagnostics sector may find Waters Corporation (NYSE: WAT) an intriguing prospect. With a market capitalization of $32.7 billion, Waters Corporation stands out as a..

Gilead Sciences, Inc. (GILD) Stock Report: Navigating Market Dynamics with a 2.17% Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, particularly within the realm of biopharmaceuticals. With a current market capitalization of $187.84 billion, this United..

Bristol-Myers Squibb (BMY) Stock Analysis: Unpacking the Healthcare Giant’s Potential Upside

For investors eyeing the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust portfolio and strategic positioning in the drug manufacturing industry. With a market..

Sanofi (SNY) Investor Outlook: High Dividend Yield with 23% Upside Potential

Sanofi (SNY), the French pharmaceutical giant, is a prominent player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $113.57 billion, Sanofi is a..

Stryker Corporation (SYK) Stock Analysis: Unpacking the 11.62% Potential Upside for Savvy Investors

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is a key player within the medical devices industry, boasting a substantial market capitalization of $145.51 billion. Headquartered in Portage,..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Heavyweight with 11.83% Potential Upside

Cencora, Inc. (COR), a titan in the healthcare sector, has been making waves in the medical distribution industry with a market capitalization of $70.24 billion. As the company continues to..

Abbott Laboratories (ABT) Investor Outlook: Exploring a Promising 18.87% Potential Upside

Abbott Laboratories (ABT), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and diverse product portfolio. With a market capitalization of $195.3 billion,..

Natera, Inc. (NTRA) Stock Analysis: High Growth Potential with 21.25% Upside

For investors seeking opportunities in the healthcare sector, Natera, Inc. (NASDAQ: NTRA) offers a compelling case with its robust growth potential and innovative diagnostic solutions. With a market capitalization of..

argenx SE (ARGX) Stock Analysis: Potential 21.89% Upside and Robust Revenue Growth

argenx SE (NASDAQ: ARGX), a dynamic player in the biotechnology sector, is garnering substantial attention from investors thanks to its impressive growth metrics and strong market presence. With a market..

Fresenius Medical Care AG (FMS): Investor Outlook on a Healthcare Giant with 15% Upside Potential

Fresenius Medical Care AG (FMS), a titan in the healthcare sector, is a German-based company specializing in dialysis and related services for patients with renal diseases. With a towering market..

Royalty Pharma (RPRX) Stock Report: Analysts See a 13% Upside Potential Amid Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) continues to make waves in the biotechnology sector with its unique business model that capitalizes on the vast potential of biopharmaceutical royalties. Based in New..

Centene Corporation (CNC) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare industry, with a market capitalization of $21.26 billion. Operating in the healthcare plans sector, Centene provides a variety of..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 13% Potential Upside in the Booming Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology powerhouse, is capturing investor attention with its robust pipeline and a promising 13% potential upside, according to the latest analyst ratings. Positioned in..

Labcorp Holdings Inc. (LH) Stock Analysis: A Promising 8.21% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, operates within the Diagnostics & Research industry, offering a broad spectrum of laboratory services. With a market capitalization..

Novartis AG (NVS) Stock Analysis: Navigating a Challenging Market with a 30.81% Return on Equity

Novartis AG (NVS), a titan in the healthcare sector, continues to make waves in the pharmaceutical industry with its robust portfolio of innovative treatments. Despite the current challenges reflected in..

Edwards Lifesciences (EW) Investor Outlook: Exploring a Potential 20.96% Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, continues to captivate investor interest with its robust growth potential and innovative product offerings. Based in Irvine, California,..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Strong Buy with 30.44% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a colossal entity in the healthcare sector, particularly in diagnostics and research, continues to capture the interest of investors. With a market capitalization of..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 68.74% Potential Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a titan in the healthcare sector focusing on health information services, is a company that continues to capture the attention of investors with its robust..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds